| IHE | iShares U.S. Pharmaceuticals ETF | $111.08 | ― | 258.32K | 242.04K | $128.31(15.52% Upside) | Moderate Buy | 54 | 0.37% | $1.72B | | 69neutral |
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | $44.56 | ― | 120.45K | 167.09K | $48.95(9.84% Upside) | Moderate Buy | 51 | 0.60% | $1.21B | | 72outperform |
| PPH | VanEck Pharmaceutical ETF | $121.71 | ― | 236.03K | 325.17K | $135.90(11.66% Upside) | Moderate Buy | 26 | 0.36% | $1.09B | | 72outperform |
| PJP | Invesco Dynamic Pharmaceuticals ETF | $131.20 | ― | 19.73K | 34.87K | $161.05(22.75% Upside) | Moderate Buy | 29 | 0.58% | $603.91M | | 69neutral |
| XPH | SPDR S&P Pharmaceuticals ETF | $68.82 | ― | 72.16K | 201.31K | $108.96(58.33% Upside) | Strong Buy | 62 | 0.35% | $512.11M | | 58neutral |
| LLYX | Defiance Daily Target 2X Long LLY ETF | $36.26 | ― | 163.58K | 281.19K | ― | ― | 3 | 1.49% | $42.60M | ― | ― |
| NVOX | Defiance Daily Target 2X Long NVO ETF | $10.79 | ― | 243.14K | 397.75K | ― | ― | 3 | 1.31% | $34.71M | ― | ― |
| ELIL | Direxion Daily LLY Bull 2X Shares | $41.37 | ― | 28.41K | 68.28K | ― | ― | 2 | 1.07% | $24.68M | ― | ― |
| NVOH | Novo Nordisk A/S (B Shares) ADRhedged | $23.40 | ― | 3.10K | 1.14K | $24.02(2.67% Upside) | Hold | 2 | 0.19% | $3.91M | | 68neutral |
| GSKH | GSK plc ADRhedged | $71.78 | ― | 429.00 | 332.00 | $82.46(14.87% Upside) | Moderate Buy | 2 | 0.19% | $722.03K | | 75outperform |
| NVOC | Corgi NVO 2x Daily ETF | $16.31 | ― | 14.00 | 550.00 | ― | ― | 2 | 0.45% | $247.59K | ― | ― |
